Actinogen optimizes XanaMIA Phase 2b Alzheimer's disease trial design and provides general business update
/PRNewswire/ -- XanaMIA Phase 2b trial...
Stay updated with breaking news from Paul Maruff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- XanaMIA Phase 2b trial...
Toronto, ON (PRWEB) December 01, 2022 -- With the first demonstration that anti-amyloid therapies can slow amyloid accumulation and reduce clinical disease
Automated digital speech measures can detect subtle cognitive-linguistic and fine motor features in presymptomatic individuals who carry the expanded Huntington's disease gene.
Drinking coffee may reduce your risk of Alzheimer’s disease, according to findings published in the journal Frontiers in Aging Neuroscience. The study followed a sample of older adults for 10 years and found that those who consumed more coffee showed slower cognitive decline, slower Aβ-amyloid accumulation, and a lower likelihood of Alzheimer’s disease. ...
Toronto, ON (PRWEB) April 07, 2022 -- Long COVID has many terms, such as post-acute sequelae of SARS-CoV-2 infection (PASC), commonly known as post-acute